Symbols

AIDX

20/20 Biolabs·NASDAQ

--(--)

7.63 / 10

Outperform

Fund flow metrics score 7.63/10, revealing robust fund flow characteristics. Beneficial Medium trends are challenged by problematic overall, block, Small, Large, and Extra-large signals, indicating positive capital movement.

Fund Flow Rating

What is the market sentiment for AIDX?

AIDX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.63/10 (Outperform).